Efficacy and safety of interferon β-1a in treatment of severe COVID-19: A randomized clinical trial

Effat Davoudi-Monfared, Hamid Rahmani, Hossein Khalili, Mahboubeh Hajiabdolbaghi, Mohamadreza Salehi, Ladan Abbasian, Hossein Kazemzadeh, Mir Saeed Yekaninejad
doi: https://doi.org/10.1101/2020.05.28.20116467

Article usage

Article usage: May 2020 to January 2025

AbstractFullPdf
May 202018980236
Jun 202026090729
Jul 202020380570
Aug 202010040295
Sep 20204780180
Oct 20203850128
Nov 20203360156
Dec 20203301114
Jan 20212846111
Feb 2021184157
Mar 2021118674
Apr 20211572111
May 2021176481
Jun 2021134078
Jul 2021104583
Aug 2021121659
Sep 2021157368
Oct 2021130566
Nov 2021141157
Dec 2021157118
Jan 20221211039
Feb 202280121
Mar 202286318
Apr 2022135129
May 2022110032
Jun 202290043
Jul 202270233
Aug 202283133
Sep 2022111127
Oct 2022105053
Nov 2022168052
Dec 2022154128
Jan 202397221
Feb 202384435
Mar 202352044
Apr 202337338
May 202322131
Jun 202314422
Jul 202319225
Aug 2023421435
Sep 202387536
Oct 2023107227
Nov 20231541429
Dec 202387213
Jan 202482016
Feb 2024106426
Mar 2024122218
Apr 2024110422
May 2024125123
Jun 2024114421
Jul 2024111517
Aug 2024127520
Sep 2024115230
Oct 20241251059
Nov 2024134422
Dec 2024137125
Jan 2025112113
Back to top
Posted May 30, 2020.
Download PDF
Data/Code
Email
Efficacy and safety of interferon β-1a in treatment of severe COVID-19: A randomized clinical trial
Effat Davoudi-Monfared, Hamid Rahmani, Hossein Khalili, Mahboubeh Hajiabdolbaghi, Mohamadreza Salehi, Ladan Abbasian, Hossein Kazemzadeh, Mir Saeed Yekaninejad
medRxiv 2020.05.28.20116467; doi: https://doi.org/10.1101/2020.05.28.20116467
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area